Search results
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 4 hours agoPfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 5 hours agoLilly currently has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank...
Pfizer stock price analysis: how PFE became a fallen angel | Invezz
Invezz· 3 days agoPfizer (NYSE: PFE) stock price has crashed hard in the past few years as demand for Covid-19...
FDA Expands Sarepta's (SRPT) DMD Gene Therapy Label
Zacks via Yahoo Finance· 2 hours agoFollowing the label expansion, Sarepta's (SRPT) Elevidys is approved to treat all DMD patients aged four years and older, regardless of ambulation...
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider
Zacks via Yahoo Finance· 3 days agoPrior to today's trading, shares of the drugmaker had lost 5.43% over the past month. This...that...
7,403 Shares in Pfizer Inc. (NYSE:PFE) Bought by Gerber LLC
ETF DAILY NEWS· 4 days agoGerber LLC bought a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 7,403 shares of the biopharmaceutical ...
Sarepta Catapults 39% After Hitting A 'Grand Slam' Approval In Muscular Dystrophy
Investor's Business Daily· 3 hours agoSarepta stock rocketed Friday after hitting a "grand slam" approval that expands the market for its...
Sarepta Stock Surges on Expanded Elevidys Approval. It’s a ‘Best-Case’ Scenario for Shares.
Barrons.com· 3 hours agoThe biopharmaceutical company says the drug was approved for ambulatory and non-ambulatory people,...
Sarepta Skyrockets After FDA Signs Off On Duchenne Gene Therapy
Investor's Business Daily· 7 hours agoLast year, the FDA granted the Sarepta Therapeutics (SRPT) gene therapy, dubbed Elevidys, an accelerated approval for children ages 4 and 5 with Duchenne muscular dystrophy. Now Thursday night ...
Market Today: Boeing Delays 737 Production, Pfizer Extends Losse
Guru Focus· 7 days agoMarket Performance Overview The S&P 500 and Nasdaq Composite hit fresh record highs this week,...